Anna Tsitouridou

Nanotechnology has emerged as a new revolution in the field of medical and health sciences and has enabled, amongst others, the development of drug delivery systems with enhanced biocompatibility and reduced side effects. However, the commercialization of nanotherapeutics faces major challenges, such as lack of quality control, scalability and low reproducibility. Microfluidics has demonstrated enormous potential to address challenges with existing formulation methods, providing emerging approach to be established in the pharmaceutical industry. Microfluidic systems are mainly characterised by controllability, flexibility and portability, whilst they reduce the manufacturing time and increase efficiency. 

This research project aims to provide a sustainable and cost-effective technology for manufacturing nanomaterials. The utilization of commercial and novel microfluidic platforms is studied for efficient formulation of nanodrug delivery systems. Strategies for process scale-up  are developed. This project combines experimental work, numerical simulations and machine learning methods for process optimization.